{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T19:55:31Z","timestamp":1787601331969,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.clnesp.2025.11.132","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:34:14Z","timestamp":1764722054000},"page":"102817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Positive clinical outcomes associated with use of glucagon-like peptide-2 (GLP-2) analogues in patients with intestinal failure: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0306-3940","authenticated-orcid":false,"given":"Alysia","family":"Bastas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clnesp.2025.11.132_bib1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.clnu.2014.08.017","article-title":"ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults","volume":"34","author":"Pironi","year":"2015","journal-title":"Clin Nutr"},{"issue":"9","key":"10.1016\/j.clnesp.2025.11.132_bib2","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.1016\/j.clnu.2021.07.002","article-title":"ESPEN practical guideline: clinical nutrition in chronic intestinal failure","volume":"40","author":"Cuerda","year":"2021","journal-title":"Clin Nutr"},{"issue":"5","key":"10.1016\/j.clnesp.2025.11.132_bib3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ncp.10180","article-title":"Early history of home parenteral nutrition: from hospital to home","volume":"33","author":"Hurt","year":"2018","journal-title":"Nutr Clin Pract"},{"issue":"7","key":"10.1016\/j.clnesp.2025.11.132_bib4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jpen.1609","article-title":"Epidemiology of infectious and noninfectious catheter complications in patients receiving home parenteral nutrition: a systematic review and meta-analysis","volume":"43","author":"Reitzel","year":"2019","journal-title":"J Parenter Enteral Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2025.11.132_bib5","article-title":"Is home parenteral nutrition safe for cancer patients? Positive effects and potential catheter-related complications: a systematic review","volume":"28","author":"Ozcelik","year":"2019","journal-title":"Eur J Cancer Care"},{"issue":"6","key":"10.1016\/j.clnesp.2025.11.132_bib6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S0016-5085(03)00326-3","article-title":"Management of complications in patients receiving home parenteral nutrition","volume":"124","author":"Howard","year":"2003","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.clnesp.2025.11.132_bib7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.7326\/0003-4819-132-7-200004040-00003","article-title":"Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure","volume":"132","author":"Cavicchi","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clnesp.2025.11.132_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.clnesp.2018.07.006","article-title":"The impact of home parenteral nutrition on the burden of disease including morbidity, mortality and rate of hospitalisations","volume":"28","author":"Burden","year":"2018","journal-title":"Clin Nutr ESPEN"},{"issue":"2","key":"10.1016\/j.clnesp.2025.11.132_bib9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.clnu.2016.01.028","article-title":"Survival and nutritional dependence on home parenteral nutrition: three decades of experience from a single referral centre","volume":"36","author":"Dibb","year":"2017","journal-title":"Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2025.11.132_bib10","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/gut.50.3.428","article-title":"Gut adaptation and the glucagon-like peptides","volume":"50","author":"Drucker","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.clnesp.2025.11.132_bib11","series-title":"Physiology of the gastrointestinal tract","first-page":"435","article-title":"Chapter 15 - regulation of gastrointestinal normal cell growth","author":"Hellmich","year":"2006"},{"issue":"7","key":"10.1016\/j.clnesp.2025.11.132_bib12","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jcem.84.7.5840","article-title":"Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2","volume":"84","author":"W\u00f8jdemann","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.clnesp.2025.11.132_bib13","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1080\/00365520802538195","article-title":"Glucagon-like peptide-2 increases mesenteric blood flow in humans","volume":"44","author":"Bremholm","year":"2009","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"10.1016\/j.clnesp.2025.11.132_bib14","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.cgh.2022.05.032","article-title":"AGA clinical practice update on management of short bowel syndrome: expert review","volume":"20","author":"Iyer","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.clnesp.2025.11.132_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/14728214.2024.2357567","article-title":"Emerging drugs for the treatment of short bowel syndrome","volume":"29","author":"Frau","year":"2024","journal-title":"Expet Opin Emerg Drugs"},{"key":"10.1016\/j.clnesp.2025.11.132_bib16","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"Br Med J"},{"key":"10.1016\/j.clnesp.2025.11.132_bib17","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Br Med J"},{"issue":"8","key":"10.1016\/j.clnesp.2025.11.132_bib18","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/nu15081949","article-title":"Quality of life in teduglutide-treated patients with short bowel syndrome intestinal Failure-A nested matched pair real-world study","volume":"15","author":"Bl\u00fcthner","year":"2023","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.clnesp.2025.11.132_bib19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jpen.1588","article-title":"Impact of teduglutide on quality of life among patients with short bowel syndrome and intestinal failure","volume":"44","author":"Chen","year":"2020","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"7","key":"10.1016\/j.clnesp.2025.11.132_bib20","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jpen.2549","article-title":"Adult patients with short bowel syndrome treated with teduglutide: a descriptive cohort study","volume":"47","author":"Daoud","year":"2023","journal-title":"J Parenter Enteral Nutr"},{"issue":"11","key":"10.1016\/j.clnesp.2025.11.132_bib21","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.3390\/nu15112448","article-title":"Post-marketing use of teduglutide in a large cohort of adults with short bowel syndrome-associated chronic intestinal failure: Evolution and outcomes","volume":"15","author":"de Dreuille","year":"2023","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.clnesp.2025.11.132_bib22","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jpen.2272","article-title":"Teduglutide in short bowel syndrome patients: a way back to normal life?","volume":"46","author":"Harpain","year":"2022","journal-title":"J Parenter Enteral Nutr"},{"issue":"7","key":"10.1016\/j.clnesp.2025.11.132_bib23","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/gut.2010.218271","article-title":"Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and\/or intravenous fluid requirements in patients with short bowel syndrome","volume":"60","author":"Jeppesen","year":"2011","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.clnesp.2025.11.132_bib24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/j.gastro.2012.09.007","article-title":"Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure","volume":"143","author":"Jeppesen","year":"2012","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.clnesp.2025.11.132_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.clnu.2013.03.016","article-title":"Quality of life in patients with short bowel syndrome treated with the new glucagon-like peptide-2 analogue teduglutide--analyses from a randomised, placebo-controlled study","volume":"32","author":"Jeppesen","year":"2013","journal-title":"Clin Nutr"},{"issue":"9","key":"10.1016\/j.clnesp.2025.11.132_bib26","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.clnu.2019.12.019","article-title":"Six-month outcomes of teduglutide treatment in adult patients with short bowel syndrome with chronic intestinal failure: a real-world French observational cohort study","volume":"39","author":"Joly","year":"2020","journal-title":"Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2025.11.132_bib27","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/MCG.0000000000000604","article-title":"Safety and efficacy of Teduglutide (Gattex) in patients with Crohn's disease and need for parenteral support due to short bowel syndrome\u2013associated intestinal failure","volume":"51","author":"Kochar","year":"2017","journal-title":"J Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.clnesp.2025.11.132_bib28","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jpen.1011","article-title":"Single-center experience with the use of teduglutide in adult patients with short bowel syndrome","volume":"42","author":"Lam","year":"2018","journal-title":"J Parenter Enteral Nutr"},{"issue":"5","key":"10.1016\/j.clnesp.2025.11.132_bib29","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/ajcn\/nqaa412","article-title":"Imaging as predictor of clinical response to teduglutide in adult patients with short bowel syndrome with chronic intestinal failure","volume":"113","author":"Martin","year":"2021","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.clnesp.2025.11.132_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00595-022-02587-4","article-title":"Efficacy, safety, and pharmacokinetics of teduglutide in adult Japanese patients with short bowel syndrome and intestinal failure: two phase III studies with an extension","volume":"53","author":"Nakamura","year":"2023","journal-title":"Surg Today"},{"issue":"7","key":"10.1016\/j.clnesp.2025.11.132_bib31","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cgh.2012.12.029","article-title":"Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure","volume":"11","author":"O'Keefe","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.clnesp.2025.11.132_bib32","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.clnu.2018.07.030","article-title":"Experience with teduglutide treatment for short bowel syndrome in clinical practice","volume":"38","author":"Pevny","year":"2019","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnesp.2025.11.132_bib33","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jpen.1838","article-title":"Long-term outcomes with teduglutide from a single center","volume":"45","author":"Puello","year":"2021","journal-title":"J Parenter Enteral Nutr"},{"issue":"5","key":"10.1016\/j.clnesp.2025.11.132_bib34","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.clnu.2023.03.012","article-title":"Short-term clinical evaluation of teduglutide for patients with Crohn's disease on home parenteral support for postoperative short bowel syndrome with intestinal failure","volume":"42","author":"Sato","year":"2023","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2025.11.132_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/1756284818793343","article-title":"GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting","volume":"11","author":"Schoeler","year":"2018","journal-title":"Therap Adv Gastroenterol"},{"issue":"2","key":"10.1016\/j.clnesp.2025.11.132_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.69","article-title":"Long-term teduglutide for the treatment of patients with intestinal failure associated with short bowel syndrome","volume":"7","author":"Schwartz","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"issue":"4","key":"10.1016\/j.clnesp.2025.11.132_bib37","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/ncp.10092","article-title":"Reduction of parenteral nutrition and hydration support and safety with long-term teduglutide treatment in patients with short bowel syndrome\u2212associated intestinal failure: STEPS-3 study","volume":"33","author":"Seidner","year":"2018","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/j.clnesp.2025.11.132_bib38","article-title":"Glepaglutide, a long-acting glucagon-like Peptide-2 analogue, reduces parenteral support in patients with short bowel syndrome: a phase 3 randomized controlled trial","volume":"19","author":"Jeppesen","year":"2024","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.clnesp.2025.11.132_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.clnu.2024.10.011","article-title":"Efficacy and safety of apraglutide in short bowel syndrome with intestinal failure and colon\u2013in\u2013continuity: a multicenter, open-label, metabolic balance study","volume":"43","author":"Verbiest","year":"2024","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2025.11.132_bib40","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/jpen.2223","article-title":"Apraglutide, a novel glucagon-like peptide-2 analog, improves fluid absorption in patients with short bowel syndrome intestinal failure: findings from a placebo-controlled, randomized phase 2 trial","volume":"46","author":"Eliasson","year":"2022","journal-title":"JPEN - J Parenter Enter Nutr"},{"issue":"5","key":"10.1016\/j.clnesp.2025.11.132_bib41","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.clnu.2012.12.001","article-title":"Development and validation of the disease-specific short bowel syndrome-quality of life (SBS-QoLTM) scale","volume":"32","author":"Bergh\u00f6fer","year":"2013","journal-title":"Clin Nutr"},{"issue":"6846","key":"10.1016\/j.clnesp.2025.11.132_bib42","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/bmj.305.6846.160","article-title":"Validating the SF-36 health survey questionnaire: new outcome measure for primary care","volume":"305","author":"Brazier","year":"1992","journal-title":"Br Med J"},{"issue":"5","key":"10.1016\/j.clnesp.2025.11.132_bib43","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ajcnut.2024.02.031","article-title":"Cost-effectiveness of teduglutide in adult patients with short bowel syndrome \u2013 a European socioeconomic perspective","volume":"119","author":"Walter","year":"2024","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2025.11.132_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ajcn\/nqz269","article-title":"Cost-effectiveness of teduglutide in adult patients with short bowel syndrome: Markov modeling using traditional cost-effectiveness criteria","volume":"111","author":"Raghu","year":"2020","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"10.1016\/j.clnesp.2025.11.132_bib45","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/0148607193017006501","article-title":"Quality of life in long-term total parenteral nutrition patients and their family caregivers","volume":"17","author":"Smith","year":"1993","journal-title":"J Parenter Enteral Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2025.11.132_bib46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.clnu.2006.05.003","article-title":"A review of the quality of life of adult patients treated with long-term parenteral nutrition","volume":"25","author":"Baxter","year":"2006","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnesp.2025.11.132_bib47","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/014860717900300203","article-title":"Permanent total parenteral nutrition: psychological and social responses of the early stages","volume":"3","author":"Price","year":"1979","journal-title":"J Parenter Enteral Nutr"},{"issue":"4","key":"10.1016\/j.clnesp.2025.11.132_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0261-5614(95)80003-4","article-title":"Quality of life on home parenteral nutrition: a single centre study of 37 patients","volume":"14","author":"Carlso","year":"1995","journal-title":"Clin Nutr"},{"issue":"1","key":"10.1016\/j.clnesp.2025.11.132_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0261-5614(89)90019-8","article-title":"Home parenteral nutrition: effect of patients' lifestyle","volume":"8","author":"Malone","year":"1989","journal-title":"Clin Nutr"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725031250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405457725031250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T21:35:01Z","timestamp":1768944901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405457725031250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S2405457725031250"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.11.132","relation":{},"ISSN":["2405-4577"],"issn-type":[{"value":"2405-4577","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positive clinical outcomes associated with use of glucagon-like peptide-2 (GLP-2) analogues in patients with intestinal failure: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.11.132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102817"}}